高级搜索
诱导化疗联合三维适形放疗加每周化疗治疗局部晚期胃癌32 例[J]. 肿瘤防治研究, 2007, 34(10): 777-779. DOI: 10.3971/j.issn.1000-8578.2227
引用本文: 诱导化疗联合三维适形放疗加每周化疗治疗局部晚期胃癌32 例[J]. 肿瘤防治研究, 2007, 34(10): 777-779. DOI: 10.3971/j.issn.1000-8578.2227

诱导化疗联合三维适形放疗加每周化疗治疗局部晚期胃癌32 例

  • 摘要: 目的 探讨局部晚期胃癌的综合治疗方法。方法 32例局部晚期胃癌患者进入研究,以氟尿嘧啶为基础的联合方案诱导化疗2~3个周期后休息2~3周,采用三维适形放疗同步5-Fu500rag/(m2 ·d),24h持续静脉滴注,每周1次,连续5周,亚叶酸钙200mg/m2 ·d,24h持续静脉滴注,每周1次,连续5周。结果 32例适合进行统计分析,其1、3、5年生存率及局控率分别为90.6%、56.3%、37.5%及53.1%、28.1%、15.6%。主要毒副反应是胃肠道粘膜反应和粒细胞下降(主要为1~2级)。结论 诱导化疗联合三维适形放疗加同步氟尿嘧啶每周化疗治疗局部晚期胃癌可提高局部控制率,延长生存期,副反应可耐受。

     

    Abstract: Objective  To investigate the comprehensive treatment for locally advanced gastric carcinoma. Methods  32 patients with local advanced gast ric carcinoma were included into the study, received 2~3 cycles of 5-Fu-based chemotherapy followed by three-dimensional conformal radiation therapy (3DCRT) combined with chemotherapy of 5-Fu 500 mg/ (m2 ·d), int ravenous drip infusion for 24h, one time per week for successive five weeks, calcium folinate 200 mg/ (m2 ·d), int ravenous drip infusion for 24 h, one time per week for successive five weeks. Results  32 patients were eligible for the analysis. The overall survival rates of 1, 3, 5 year were 90. 6 %, 56. 3 %, 37. 5 % respectively, and the local-control rates were 53. 1 %、28. 1 %、15. 6 % respectively. The major adverse effect s were acute gast rointestinal reactions and granulocytopenia (chiefly grade Ⅰ~ Ⅱ) . Conclusion  The therapy of 3DCRT plus induction chemotherapy based on 5-Fu weekly followed by induction chemotherapy was feasible for the treatment of local advanced stomach cancer. It could increase the local-cont rol rate, elongation the survival time and the adverse effect s were tolerable.

     

/

返回文章
返回